Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 7,500 shares at $29.15 ($220K) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $220k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.15 | 6,000 | $175K | 79.4% |
| 2 | $30.01 | 1,100 | $33K | 15.0% |
| 3 | $30.90 | 400 | $12K | 5.6% |
| Total | $29.37 avg | 7,500 | $220K | 100% |
| Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |
| NRIX | SELL | 2021-03-09 | $548K | — | Filing → |